Padoan, Rita
Padoan, Rita
Dipartimento di Scienze Cliniche e Sperimentali
Asymptomatic case of Covid-19 in an infant with cystic fibrosis
2020-01-01 Poli, P.; Timpano, S.; Goffredo, M.; Padoan, R.; Badolato, R.
Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
2021-01-01 Baresi, G.; Giacomelli, M.; Moratto, D.; Chiarini, M.; Conforti, I. C.; Padoan, R.; Poli, P.; Timpano, S.; Caldarale, F.; Badolato, R.
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library
2021-01-01 Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P.
Paranasal mucoceles in children with cystic fibrosis: Management of a not so rare clinical condition
2021-01-01 Rampinelli, Vittorio; Ferrari, Marco; Poli, Piercarlo; Lancini, Davide; Mattavelli, Davide; Timpano, Silviana; Redaelli de Zinis, Luca Oscar; Badolato, Raffaele; Padoan, Rita; Berlucchi, Marco
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients
2010-01-01 Chiarini, M.; Sabelli, C.; Melotti, P.; Garlanda, C.; Savoldi, G.; Mazza, C.; Padoan, R.; Plebani, A.; Mantovani, A.; Notarangelo, L. D.; Assael, B. M.; Badolato, R.
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing
2022-01-01 Fossa, Paola; Uggeri, Matteo; Orro, Alessandro; Urbinati, Chiara; Rondina, Alessandro; Milanesi, Maria; Pedemonte, Nicoletta; Pesce, Emanuela; Padoan, Rita; Ford, Robert C; Meng, Xin; Rusnati, Marco; D'Ursi, Pasqualina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Asymptomatic case of Covid-19 in an infant with cystic fibrosis | 1-gen-2020 | Poli, P.; Timpano, S.; Goffredo, M.; Padoan, R.; Badolato, R. | |
| Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic | 1-gen-2021 | Baresi, G.; Giacomelli, M.; Moratto, D.; Chiarini, M.; Conforti, I. C.; Padoan, R.; Poli, P.; Timpano, S.; Caldarale, F.; Badolato, R. | |
| In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library | 1-gen-2021 | Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P. | |
| Paranasal mucoceles in children with cystic fibrosis: Management of a not so rare clinical condition | 1-gen-2021 | Rampinelli, Vittorio; Ferrari, Marco; Poli, Piercarlo; Lancini, Davide; Mattavelli, Davide; Timpano, Silviana; Redaelli de Zinis, Luca Oscar; Badolato, Raffaele; Padoan, Rita; Berlucchi, Marco | |
| PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients | 1-gen-2010 | Chiarini, M.; Sabelli, C.; Melotti, P.; Garlanda, C.; Savoldi, G.; Mazza, C.; Padoan, R.; Plebani, A.; Mantovani, A.; Notarangelo, L. D.; Assael, B. M.; Badolato, R. | |
| Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing | 1-gen-2022 | Fossa, Paola; Uggeri, Matteo; Orro, Alessandro; Urbinati, Chiara; Rondina, Alessandro; Milanesi, Maria; Pedemonte, Nicoletta; Pesce, Emanuela; Padoan, Rita; Ford, Robert C; Meng, Xin; Rusnati, Marco; D'Ursi, Pasqualina |